DrugPatentWatch Database Preview
Drugs in Development Information for Fasudil
» See Plans and Pricing
What is the development status for investigational drug Fasudil?
Fasudil is an investigational drug.
There have been 12 clinical trials for Fasudil.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2010.
The most common disease conditions in clinical trials are Amyotrophic Lateral Sclerosis, Motor Neuron Disease, and Scleroderma, Diffuse. The leading clinical trial sponsors are Woolsey Pharmaceuticals, Brigham and Women's Hospital, and Shahid Beheshti University of Medical Sciences.
Summary for Fasudil
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,346 |
| WIPO Patent Applications | 1,759 |
| Japanese Patent Applications | 903 |
| Clinical Trial Progress | Phase 3 (2010-02-01) |
| Vendors | 61 |
Recent Clinical Trials for Fasudil
| Title | Sponsor | Phase |
|---|---|---|
| Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 | Woolsey Pharmaceuticals | Phase 2 |
| Fasudil fOr redUcing elopemeNt and Spatial Disorientation | Woolsey Pharmaceuticals | Phase 2 |
| Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial Infarction | RenJi Hospital | Phase 4 |
Clinical Trial Summary for Fasudil
Top disease conditions for Fasudil
Top clinical trial sponsors for Fasudil
US Patents for Fasudil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
